FT News Briefing The $30bn insurance broker deal that never came to be
Jul 27, 2021
Explore the potential easing of travel bans for vaccinated travelers from the US and EU, sparking hopes for tourism recovery. Learn how Intel is shifting its branding strategy to focus on performance rather than chip size amid fierce competition. Dive into the fallout from the colossal $30 billion merger collapse between Aon and Willis Towers Watson due to US regulatory issues. Celebrating success, discover how Japanese athletes are turning the tide of public sentiment at the Tokyo Olympics, bringing national pride during challenging times.
AI Snips
Chapters
Transcript
Episode notes
UK Relaxes Travel Restrictions
- Fully vaccinated US and EU citizens may soon travel to the UK without quarantining.
- However, the US maintains its travel ban due to the Delta variant.
Intel Rebrands Chips
- Intel will change how it names its chips, moving away from transistor size.
- This shift aims to highlight Intel's other strengths and de-emphasize its lag in miniaturization.
Aon-Willis Merger Blocked
- The US Department of Justice blocked the $30 billion merger between Aon and Willis Towers Watson due to antitrust concerns.
- This leaves Willis's future uncertain, as a sale to Marsh McLennan, another major player, now seems unlikely.